Access cutting-edge aphasia treatment through this clinical trial at a research site in Baltimore. Study-provided care at no cost to qualified participants.
Access aphasia specialists in Baltimore at no cost
This study follows strict safety protocols and ethical guidelines
All study-related aphasia treatment provided free
In this project, the investigators will investigate the effects of a selective serotonin reuptake inhibitor (SSRI), escitalopram, on augmenting language therapy effectiveness, as measured by naming untrained pictures and describing pictures, in individuals with aphasia in the acute and subacute post stroke period (i.e., within three months post stroke).
Sponsor: Johns Hopkins University
Check if you qualify for this aphasia clinical trial in Baltimore, MD
If you're searching for aphasia treatment options in Baltimore, MD, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Baltimore research site is actively enrolling participants for this clinical trial. You'll receive care from experienced aphasia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.